Bank of New York Mellon’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-968,076
| Closed | -$18.8M | – | 4386 |
|
|
2018
Q1 | $18.8M | Buy |
968,076
+5,381
| +0.6% | +$105K | 0.01% | 1599 |
|
|
2017
Q4 | $16M | Buy |
962,695
+37,192
| +4% | +$619K | ﹤0.01% | 1722 |
|
|
2017
Q3 | $18.8M | Sell |
925,503
-46,320
| -5% | -$940K | 0.01% | 1595 |
|
|
2017
Q2 | $15.6M | Buy |
971,823
+39,503
| +4% | +$636K | ﹤0.01% | 1699 |
|
|
2017
Q1 | $11.8M | Buy |
932,320
+55,556
| +6% | +$703K | ﹤0.01% | 1873 |
|
|
2016
Q4 | $11.6M | Sell |
876,764
-24,757
| -3% | -$328K | ﹤0.01% | 1876 |
|
|
2016
Q3 | $21.4M | Buy |
901,521
+78,667
| +10% | +$1.86M | 0.01% | 1428 |
|
|
2016
Q2 | $23.7M | Sell |
822,854
-16,084
| -2% | -$464K | 0.01% | 1300 |
|
|
2016
Q1 | $26.9M | Buy |
838,938
+28,244
| +3% | +$904K | 0.01% | 1222 |
|
|
2015
Q4 | $34.7M | Sell |
810,694
-5,979
| -0.7% | -$256K | 0.01% | 1040 |
|
|
2015
Q3 | $28.8M | Buy |
816,673
+139,124
| +21% | +$4.9M | 0.01% | 1181 |
|
|
2015
Q2 | $31.1M | Sell |
677,549
-6,533
| -1% | -$300K | 0.01% | 1185 |
|
|
2015
Q1 | $32.1M | Buy |
684,082
+3,971
| +0.6% | +$186K | 0.01% | 1156 |
|
|
2014
Q4 | $21.5M | Buy |
680,111
+9,291
| +1% | +$294K | 0.01% | 1408 |
|
|
2014
Q3 | $15.9M | Sell |
670,820
-88,861
| -12% | -$2.11M | ﹤0.01% | 1603 |
|
|
2014
Q2 | $22.8M | Buy |
759,681
+21,797
| +3% | +$654K | 0.01% | 1388 |
|
|
2014
Q1 | $19.5M | Buy |
737,884
+61,802
| +9% | +$1.63M | 0.01% | 1475 |
|
|
2013
Q4 | $17M | Buy |
676,082
+22,687
| +3% | +$570K | ﹤0.01% | 1572 |
|
|
2013
Q3 | $13.4M | Sell |
653,395
-63,507
| -9% | -$1.3M | ﹤0.01% | 1667 |
|
|
2013
Q2 | $14.3M | Buy |
+716,902
| New | +$14.3M | ﹤0.01% | 1585 |
|